annual SGA:
$975.53M+$179.88M(+22.61%)Summary
- As of today (June 22, 2025), ALNY annual SGA is $975.53 million, with the most recent change of +$179.88 million (+22.61%) on December 31, 2024.
- During the last 3 years, ALNY annual SGA has risen by +$354.89 million (+57.18%).
- ALNY annual SGA is now at all-time high.
Performance
ALNY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$239.95M-$55.39M(-18.75%)Summary
- As of today (June 22, 2025), ALNY quarterly SGA is $239.95 million, with the most recent change of -$55.39 million (-18.75%) on March 31, 2025.
- Over the past year, ALNY quarterly SGA has increased by +$29.15 million (+13.83%).
- ALNY quarterly SGA is now -18.75% below its all-time high of $295.34 million, reached on December 31, 2024.
Performance
ALNY quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$28.93B-$269.70M(-0.94%)Summary
- As of today (June 22, 2025), ALNY TTM SGA is -$28.93 billion, with the most recent change of -$269.70 million (-0.94%) on March 31, 2025.
- Over the past year, ALNY TTM SGA has dropped by -$29.75 billion (-3616.04%).
- ALNY TTM SGA is now -97905.88% below its all-time high of -$29.52 million.
Performance
ALNY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ALNY Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.6% | +13.8% | -3616.0% |
| 3 y3 years | +57.2% | +55.3% | -4704.8% |
| 5 y5 years | +103.7% | +89.3% | -5704.8% |
ALNY Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.2% | -18.8% | +55.3% | -36.0% | at low |
| 5 y | 5-year | at high | +103.7% | -18.8% | +89.3% | -101.9% | at low |
| alltime | all time | at high | >+9999.0% | -18.8% | +8042.1% | <-9999.0% | at low |
ALNY Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $239.95M(-18.8%) | $1.00B(+3.0%) |
| Dec 2024 | $975.53M(+22.6%) | $295.34M(+33.6%) | $975.53M(+11.1%) |
| Sep 2024 | - | $220.99M(-11.0%) | $878.31M(+2.5%) |
| Jun 2024 | - | $248.40M(+17.8%) | $856.49M(+4.1%) |
| Mar 2024 | - | $210.80M(+6.4%) | $822.78M(+3.4%) |
| Dec 2023 | $795.65M(+3.2%) | $198.12M(-0.5%) | $795.65M(-1.5%) |
| Sep 2023 | - | $199.18M(-7.2%) | $807.87M(-4.3%) |
| Jun 2023 | - | $214.69M(+16.9%) | $844.55M(+5.6%) |
| Mar 2023 | - | $183.66M(-12.7%) | $799.85M(+3.8%) |
| Dec 2022 | $770.66M(+24.2%) | $210.34M(-10.8%) | $770.66M(+3.2%) |
| Sep 2022 | - | $235.86M(+38.8%) | $746.70M(+14.4%) |
| Jun 2022 | - | $169.98M(+10.0%) | $652.91M(+3.9%) |
| Mar 2022 | - | $154.47M(-17.1%) | $628.25M(+1.2%) |
| Dec 2021 | $620.64M(+5.5%) | $186.38M(+31.2%) | $620.64M(+3.3%) |
| Sep 2021 | - | $142.07M(-2.2%) | $600.55M(-4.1%) |
| Jun 2021 | - | $145.32M(-1.0%) | $625.95M(+2.9%) |
| Mar 2021 | - | $146.86M(-11.7%) | $608.52M(+3.4%) |
| Dec 2020 | $588.42M(+22.8%) | $166.29M(-0.7%) | $588.42M(+1.7%) |
| Sep 2020 | - | $167.47M(+30.9%) | $578.41M(+8.9%) |
| Jun 2020 | - | $127.90M(+0.9%) | $531.28M(+2.9%) |
| Mar 2020 | - | $126.76M(-18.9%) | $516.16M(+7.8%) |
| Dec 2019 | $479.00M(+25.3%) | $156.28M(+29.9%) | $479.00M(+11.0%) |
| Sep 2019 | - | $120.35M(+6.7%) | $431.42M(+0.9%) |
| Jun 2019 | - | $112.77M(+25.8%) | $427.61M(+7.0%) |
| Mar 2019 | - | $89.61M(-17.6%) | $399.52M(+4.5%) |
| Dec 2018 | $382.36M(+91.8%) | $108.69M(-6.7%) | $382.36M(+12.1%) |
| Sep 2018 | - | $116.55M(+37.6%) | $341.13M(+25.3%) |
| Jun 2018 | - | $84.68M(+16.9%) | $272.23M(+16.7%) |
| Mar 2018 | - | $72.45M(+7.4%) | $233.32M(+17.0%) |
| Dec 2017 | $199.37M(+123.1%) | $67.45M(+41.6%) | $199.37M(+24.8%) |
| Sep 2017 | - | $47.64M(+4.1%) | $159.79M(+18.8%) |
| Jun 2017 | - | $45.78M(+18.9%) | $134.53M(+26.0%) |
| Mar 2017 | - | $38.49M(+38.1%) | $106.74M(+19.5%) |
| Dec 2016 | $89.35M(+47.4%) | $27.88M(+24.5%) | $89.35M(+13.5%) |
| Sep 2016 | - | $22.39M(+24.5%) | $78.71M(+8.8%) |
| Jun 2016 | - | $17.99M(-14.8%) | $72.35M(+4.9%) |
| Mar 2016 | - | $21.10M(+22.5%) | $68.99M(+13.8%) |
| Dec 2015 | $60.61M(+36.1%) | $17.23M(+7.4%) | $60.61M(+5.3%) |
| Sep 2015 | - | $16.04M(+9.7%) | $57.57M(+11.9%) |
| Jun 2015 | - | $14.62M(+14.9%) | $51.43M(+6.4%) |
| Mar 2015 | - | $12.72M(-10.3%) | $48.33M(+8.5%) |
| Dec 2014 | $44.53M | $14.19M(+43.3%) | $44.53M(+15.1%) |
| Sep 2014 | - | $9.90M(-14.1%) | $38.67M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $11.52M(+29.1%) | $35.54M(+19.2%) |
| Mar 2014 | - | $8.93M(+7.1%) | $29.81M(+9.8%) |
| Dec 2013 | $27.15M(-37.9%) | $8.33M(+23.1%) | $27.15M(-6.3%) |
| Sep 2013 | - | $6.77M(+17.0%) | $28.99M(-17.3%) |
| Jun 2013 | - | $5.78M(-7.7%) | $35.03M(-13.4%) |
| Mar 2013 | - | $6.27M(-38.4%) | $40.48M(-7.4%) |
| Dec 2012 | $43.72M(+14.2%) | $10.17M(-20.6%) | $43.72M(-1.1%) |
| Sep 2012 | - | $12.81M(+14.1%) | $44.22M(+9.6%) |
| Jun 2012 | - | $11.23M(+18.0%) | $40.37M(+7.5%) |
| Mar 2012 | - | $9.51M(-10.9%) | $37.57M(-1.9%) |
| Dec 2011 | $38.28M(+2.4%) | $10.67M(+19.2%) | $38.28M(+10.0%) |
| Sep 2011 | - | $8.96M(+6.2%) | $34.80M(+0.1%) |
| Jun 2011 | - | $8.43M(-17.6%) | $34.77M(-4.6%) |
| Mar 2011 | - | $10.22M(+42.2%) | $36.45M(-2.5%) |
| Dec 2010 | $37.40M(-6.3%) | $7.19M(-19.4%) | $37.40M(-13.7%) |
| Sep 2010 | - | $8.93M(-11.7%) | $43.33M(-3.9%) |
| Jun 2010 | - | $10.11M(-9.5%) | $45.08M(+3.9%) |
| Mar 2010 | - | $11.17M(-14.9%) | $43.37M(+8.7%) |
| Dec 2009 | $39.91M(+47.2%) | $13.12M(+22.8%) | $39.91M(+17.2%) |
| Sep 2009 | - | $10.68M(+27.2%) | $34.07M(+12.6%) |
| Jun 2009 | - | $8.40M(+8.8%) | $30.25M(+4.5%) |
| Mar 2009 | - | $7.72M(+6.1%) | $28.96M(+6.8%) |
| Dec 2008 | $27.11M(+15.9%) | $7.27M(+6.0%) | $27.11M(+6.8%) |
| Sep 2008 | - | $6.86M(-3.4%) | $25.38M(-4.4%) |
| Jun 2008 | - | $7.11M(+21.0%) | $26.55M(+7.4%) |
| Mar 2008 | - | $5.87M(+6.0%) | $24.72M(+5.7%) |
| Dec 2007 | $23.39M(+40.6%) | $5.54M(-31.1%) | $23.39M(+4.1%) |
| Sep 2007 | - | $8.04M(+52.4%) | $22.48M(+22.0%) |
| Jun 2007 | - | $5.27M(+16.1%) | $18.42M(+4.2%) |
| Mar 2007 | - | $4.54M(-1.9%) | $17.68M(+5.7%) |
| Dec 2006 | $16.63M(+19.9%) | $4.63M(+16.2%) | $16.73M(+5.8%) |
| Sep 2006 | - | $3.98M(-12.1%) | $15.80M(-0.7%) |
| Jun 2006 | - | $4.53M(+26.4%) | $15.91M(+9.7%) |
| Mar 2006 | - | $3.58M(-3.3%) | $14.50M(+4.6%) |
| Dec 2005 | $13.87M(+16.2%) | $3.71M(-9.3%) | $13.87M(+5.4%) |
| Sep 2005 | - | $4.09M(+30.9%) | $13.16M(+9.4%) |
| Jun 2005 | - | $3.12M(+5.8%) | $12.04M(+1.5%) |
| Mar 2005 | - | $2.95M(-1.6%) | $11.86M(-0.7%) |
| Dec 2004 | $11.94M(+58.6%) | $3.00M(+1.2%) | $11.94M(+33.5%) |
| Sep 2004 | - | $2.96M(+0.5%) | $8.94M(+49.5%) |
| Jun 2004 | - | $2.95M(-2.8%) | $5.98M(+97.2%) |
| Mar 2004 | - | $3.03M | $3.03M |
| Dec 2003 | $7.53M(+755.3%) | - | - |
| Dec 2002 | $880.00K | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual SGA year-on-year change?
- What is Alnylam Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly SGA year-on-year change?
- What is Alnylam Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM SGA year-on-year change?
What is Alnylam Pharmaceuticals annual SGA?
The current annual SGA of ALNY is $975.53M
What is the all time high annual SGA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual SGA is $975.53M
What is Alnylam Pharmaceuticals annual SGA year-on-year change?
Over the past year, ALNY annual SGA has changed by +$179.88M (+22.61%)
What is Alnylam Pharmaceuticals quarterly SGA?
The current quarterly SGA of ALNY is $239.95M
What is the all time high quarterly SGA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly SGA is $295.34M
What is Alnylam Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ALNY quarterly SGA has changed by +$29.15M (+13.83%)
What is Alnylam Pharmaceuticals TTM SGA?
The current TTM SGA of ALNY is -$28.93B
What is the all time high TTM SGA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM SGA is -$29.52M
What is Alnylam Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ALNY TTM SGA has changed by -$29.75B (-3616.04%)